ENTPD1 and hepatocellular carcinoma: On the Treg panel, CD28- CD8br %CD8br and CD127 on CD45RA + CD4 + could decrease the risk of HCC while CD39 on granulocyte and CD8 on CD39 + CD8br could increase the risk of HCC.